Celaid Therapeutics has concluded a joint research agreement with the Institute of Medical Science, the University of Tokyo (Division of Stem Cell Biology, specially appointed associate professor Satoshi Yamazaki) on the development of basic technology, and its applied research, aimed at the clinical application of HSCs.
Through this joint research, we will be working to promote development aimed at clinical application.